FLINDERSIAMINE
UNII 6Q8RKP2039

Substance Identification & Data

This profile provides standardized clinical and technical data for Flindersiamine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6Q8RKP2039.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 522-06-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
6Q8RKP2039
CAS Registry Number
522-06-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
FLINDERSIAMINE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C14H11NO5
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
IMJCEVWDXKCHOI-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
o1ccc2c1nc3c(OC)c4OCOc4cc3c2OC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Flindersiamine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

FLINDERSIAMIN
FLINDERSIAMINE

Systematic Nomenclature

1,3-DIOXOLO(4,5-G)FURO(2,3-B)QUINOLINE, 4,9-DIMETHOXY-
4,9-DIMETHOXY-1,3-DIOXOLO(4,5-G)FURO(2,3-B)QUINOLINE

Technical Codes

NSC-284684